Michael D. Wortley is CLO at REATA PHARMACEUTICALS INC (RETA). They have made 7 open-market trades across 1 company since 2019, most recently 2023-09-26.
CIK 0001034320
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RETA | SELL | 2023-08-15 | 2023-08-17 | $168.95 | $407K | -0.1% | +1.8% | N/A |
| RETA | SELL | 2023-05-15 | 2023-05-17 | $84.09 | $185K | +10.2% | +14.7% | +107.8% |
| RETA | SELL | 2023-03-07 | 2023-03-08 | $84.46 | $35K | +9.4% | +15.0% | +15.0% |
| RETA | SELL | 2023-03-03 | 2023-03-06 | $87.57 | $380K | +2.8% | +6.0% | +5.3% |
| RETA | SELL | 2020-11-11 | 2020-11-12 | $179.31 | $18.0M | -6.8% | -33.1% | -31.6% |
| RETA | SELL | 2019-03-05 | 2019-03-07 | $100.64 | $3.9M | +3.3% | -2.0% | -2.3% |
| RETA | SELL | 2019-03-05 | 2019-03-07 | $100.13 | $2.7M | +3.3% | -2.0% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.